Simonetto, Hui-yin MI-503 price Yang, Thiago de Assuncao, Shuchong Pan, Robert Simari, Vijay Shah Parallel 27: Genetic Liver Disease Monday, November 4 4:45 – 6:15 PM Room 152B MODERATORS: Kyle E. Brown, MD Jeffrey Teckman, MD 4:45 PM 181: The rate of disappearance of intracellular α-1-antitrypsin correlates with liver disease severity in iPSc- derived hepatocytes generated from PIZZ α-1-antitrypsin deficiency patients Edgar N. Tafaleng, Bing Han, Pamela D. Hale, Souvik Chakraborty, Alejandro Soto-Gutierrez, Carol Feghali-Bostwick, Darrell Kotton, Masaki Nagaya, Stephen A. Duncan, Donna B. Stolz, Stephen Strom, Jayanta Roy-Chowdhury, David H. Perlmutter, Ira J. Fox
5:00 PM 182: Administration of an iron-deficient Pexidartinib diet attenuates diet-induced hepatic steatosis in HFE-associated nonalcoholic fatty liver disease using Hfe-/-mice Ashley S. Wilkinson, Kim Bridle, Laurence Britton, Lesley Jaskowski, Linda M. Fletcher, V
Nathan Subramaniam, Darrell H. Crawford 5:15 PM 183: Iron activation of hepcidin in hemojuvelin knockout mice preferentially targets splenic but not intestinal ferroportin Konstantinos Gkouvatsos, Carine Fillebeen, John Wagner, Alina Daba, Giada Sebastiani, Kostas Pantopoulos 5:30 PM 184: Open label, phase-II clinical study, to evaluate the efficacy of lanreotide 90mg in symptomatic polycystic liver disease, including dose escalation at month 6 in non-responders Frederik J. Temmerman, Thien Anh Ho, Ragna Vanslembrouck, Walter Coudyzer, Vincent De Ruyter, Jos van Pelt, Bert Bammens, Yves Pirson, Frederik Nevens 5:45 PM 185: Relapse of porphyria cutanea tarda after achieving remission with phlebotomy or low dose hydroxychloroquine Ashwani K. Singal, Eric Gou, Marisol Albuerne, Csilla Kormos Hallberg, Karl E. Anderson 6:00 PM 186: Wilson’s disease: effects of gestational methyl group supplementation on global DNA methylation and gene expression in fetal mouse liver Valentina Medici, Noreene Shibata, Kusum K. Kharbanda, Mohammad S. Islam, Charles H. Halsted, Janine M. LaSalle Parallel
28: HBV Natural History and Long Term Outcomes Monday, November 4 4:45 – 6:15 PM Room 145 MODERATORS: Mindie H. Nguyen, MD Marc G. Ghany, MD 4:45 PM 187: Antibody http://www.selleck.co.jp/products/Cisplatin.html Levels and Protection after Hepatitis B Vaccine: Results of a 30 year Follow-up Study and Response to a Booster Dose Michael Bruce, Dana J. Bruden, Debby Hurlburt, Carolyn Zanis, Gail C. Thompson, Lisa D. Rea, Michele Toomey, Lisa J. Townshend-Bulson, Karen Rudolph, Lisa Bulkow, Philip Spradling, Richard Baum, Thomas W. Hennessy, Brian J. McMahon 5:00 PM 188: Reduction in eGFR in patients with chronic hepatitis B. An analysis of the Italian Master-B cohort Giuseppina Brancaccio, Alessandra Nardi, Salvatore Madonia, Massimo Fasano, Pietro Andreone, Marco Massari, Gianluca Svegliati Baroni, Barbara Coco, Alfredo Marzano, Enzo Petrelli, Gioacchino Angarano, Caius Gavrila, Giovanni B.